Recombinant Acidianus bottle-shaped virus Putative transmembrane protein ORF92 (ORF92)

Shipped with Ice Packs
In Stock

Description

Biochemical Properties

The protein is purified under denaturing conditions and stabilized in Tris/PBS buffer with 6% trehalose (pH 8.0) to prevent aggregation. Functional assays remain limited due to the protein’s uncharacterized role in ABV biology .

ParameterSpecification
FormLyophilized powder
SolubilityReconstitutes in deionized water (0.1–1.0 mg/mL)
Stabilizers6% trehalose; glycerol (optional for long-term storage)
Endotoxin Levels<1.0 EU/μg (upon request)
Storage-20°C/-80°C; avoid repeated freeze-thaw cycles

Genomic Context and Functional Insights

ORF92 is encoded by the ABV genome, a 23.8-kb linear dsDNA virus with 57 open reading frames (ORFs). Key genomic features:

Genomic AttributeDetails
Genome PositionNucleotides 11,839–12,117 (NC_009452.1)
Host SpecificityAcidianus spp. (hyperthermophilic archaea; growth at 80–95°C, pH 1.5–2.0)
HomologyNo significant matches in public databases beyond ABV strains
Functional AnnotationPutative transmembrane protein; exact role in viral replication unconfirmed

Research Applications

  • Membrane protein studies: Structural analysis of archaeal viral transmembrane domains under acidic, high-temperature conditions .

  • Antigen production: Potential use in antibody generation for ABV detection in environmental samples .

  • Comparative virology: Investigating evolutionary links between archaeal and bacterial/eukaryotic viruses .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them in your order notes. We will accommodate your request if possible.
Lead Time
Delivery times may vary based on the purchase method and location. Please consult your local distributors for specific delivery details.
Note: All our proteins are shipped with standard blue ice packs by default. If you require dry ice shipping, please communicate this in advance, as additional fees will apply.
Notes
Repeated freeze-thaw cycles are not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on factors such as storage conditions, buffer composition, storage temperature, and the protein's inherent stability. Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C, while lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
ORF92; Putative transmembrane protein ORF92
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-92
Protein Length
full length protein
Species
Acidianus bottle-shaped virus (isolate Italy/Pozzuoli) (ABV)
Target Names
ORF92
Target Protein Sequence
MSLIGLDLFDFVKGIVLLALTSGATYAIGKQFFSSNYCAIARIIQALLLFASSFLFDSAG ALILGVIVLIIGVGNYLAETNSKFAFLDPNLA
Uniprot No.

Target Background

Database Links

KEGG: vg:5129806

Subcellular Location
Host membrane; Multi-pass membrane protein.

Q&A

What is the Acidianus bottle-shaped virus and what makes it scientifically significant?

The Acidianus bottle-shaped virus (ABV) infects strains of hyperthermophilic archaea belonging to the genus Acidianus and possesses a morphology entirely distinct from all other characterized viruses. Its genomic structure consists of linear double-stranded DNA containing 23,814 base pairs with a G+C content of 35% and exhibits a 590-bp inverted terminal repeat. The virus has been taxonomically assigned to the family Ampullaviridae based on its unique characteristics. The scientific significance of ABV lies in its exceptional isolation environment (hot acidic springs at 93°C, pH 1.5) and its genomic organization, which reveals potential evolutionary links between archaeal, bacterial, and eukaryotic viruses. Of particular interest, one region at the end of the ABV linear genome shows similarities in both gene content and organization to corresponding regions in bacteriophage φ29 and human adenovirus, suggesting possible shared mechanisms of DNA replication and packaging .

What are the primary structural characteristics of the ORF92 protein?

The ORF92 protein is a putative transmembrane protein encoded by the Acidianus bottle-shaped virus genome. It consists of 92 amino acids with the following sequence: MSLIGLDLFDFVKGIVLLALTSGATYAIGKQFFSSNYCAIARIIQALLLFASSFLFDSAGALILGVIVLIIGVGNYLAETNSKFAFLDPNLA. The protein has a molecular weight of approximately 9,754 Da and is predicted to contain transmembrane domains, as indicated by its classification as a putative transmembrane protein . The gene encoding this protein is located at position NC_009452.1 (11839..12117) in the ABV genome. Computational structural analysis is available through ModBase for the protein (UniProt ID: A4ZUB3), providing researchers with predicted three-dimensional structural information that can inform functional hypotheses and experimental design .

What are the recommended expression systems for recombinant ORF92 production?

Recombinant ORF92 can be successfully expressed in multiple heterologous systems, each with distinct advantages depending on your research objectives:

Expression SystemAdvantagesConsiderationsRecommended Applications
E. coliHigh yield, rapid growth, cost-effective, well-established protocolsMay lack post-translational modifications, potential inclusion body formationInitial characterization, antibody production, structural studies
YeastEukaryotic post-translational modifications, protein folding machinery, moderate costLonger expression time than bacteria, potential hyperglycosylationFunctional studies requiring some post-translational modifications
BaculovirusAdvanced eukaryotic post-translational modifications, suitable for toxic proteinsTechnical complexity, higher cost, longer timelineComplex functional assays, interaction studies
Mammalian CellMost sophisticated post-translational modifications, native-like protein foldingHighest cost, longest timeline, technical expertise requiredAdvanced functional studies, therapeutic applications

Current literature indicates successful expression of ORF92 in E. coli with an N-terminal His-tag, achieving greater than 85-90% purity as determined by SDS-PAGE . When designing expression constructs, researchers should consider incorporating appropriate affinity tags (His, GST, MBP) to facilitate purification and detection while evaluating potential tag interference with protein function or structure. Expression optimization should include evaluation of different induction conditions, temperature, and media formulations to maximize soluble protein yield .

What experimental design approaches are most appropriate for studying ORF92 function?

For investigating ORF92 function, a rigorous experimental design should employ multiple complementary approaches:

  • Single-Case Experimental Design (SCED): This approach provides researchers with a flexible alternative to large sample size group designs, particularly valuable when working with unique viral proteins like ORF92 where replication or resource constraints may limit sample numbers. SCED methodology involves repeated, systematic assessment of variables over time, with experimental control achieved through replication of effects either within or between experimental conditions. When implementing SCED for ORF92 studies, researchers should establish a representative baseline (minimum 3-5 data points per phase), address autocorrelation issues, and carefully interpret effect sizes .

  • Randomized Controlled Experimental Design: For comparative studies evaluating ORF92 against mutant variants or other viral proteins, a randomized controlled design enhances methodological rigor and internal validity. This approach is particularly important when determining causality between ORF92 structural elements and functional outcomes .

  • Functional Genomics Approaches: Combining protein expression with genomic analyses can provide insights into ORF92's role within the ABV replication cycle. This might include transcriptomic analysis of host cells during infection, proteomics to identify interaction partners, or CRISPR-based screening to identify host factors required for ORF92 function.

The experimental framework should clearly define:

  • Independent variables (e.g., protein mutations, environmental conditions)

  • Dependent variables (e.g., membrane integration, protein-protein interactions)

  • Control conditions

  • Measurement techniques and timepoints

  • Statistical analysis methods appropriate for the data structure

Researchers should also consider the extreme environmental conditions of the native virus (93°C, pH 1.5) when designing functional assays to ensure physiological relevance .

How can structural studies of ORF92 contribute to understanding extremophilic viral adaptations?

Structural characterization of ORF92 presents unique opportunities to elucidate adaptation mechanisms of viruses to extreme environments. As a transmembrane protein from a hyperthermophilic archaeal virus that thrives at 93°C and pH 1.5, ORF92 likely possesses structural features that confer exceptional thermostability and acid resistance .

Advanced structural studies should incorporate:

  • X-ray Crystallography/Cryo-EM Analysis: Determining the three-dimensional structure at high resolution can reveal unique folding patterns, stabilizing interactions, and functional domains. This requires optimization of crystallization conditions under native-like environments.

  • Molecular Dynamics Simulations: Computational modeling of ORF92 behavior under extreme temperature and pH conditions can identify key stabilizing interactions and conformational changes. These simulations should be validated against experimental data.

  • Comparative Structural Analysis: Comparing ORF92's structure with transmembrane proteins from mesophilic viruses can highlight specific adaptations to extreme environments. This approach should utilize the ModBase 3D structure prediction for A4ZUB3 as a starting point .

  • Site-Directed Mutagenesis Combined with Stability Assays: Systematic mutation of candidate stabilizing residues followed by thermal stability assays can experimentally validate structural predictions. This approach should particularly focus on regions with unusual amino acid distributions compared to mesophilic homologs.

These structural insights could potentially reveal novel protein engineering principles applicable to biotechnology applications requiring extreme condition stability, such as industrial enzymes or therapeutic proteins with extended shelf-life .

What methodological approaches can elucidate the evolutionary relationships between ABV's putative protein-primed DNA polymerase and similar systems in bacteriophage φ29 and human adenovirus?

The ABV genome contains a region remarkably similar in both gene content and organization to corresponding regions in bacteriophage φ29 and human adenovirus, specifically encoding a putative protein-primed DNA polymerase and a small putative RNA with predicted secondary structure resembling the prohead RNA of bacteriophage φ29 . This evolutionary connection represents a fascinating area for investigation using several methodological approaches:

These approaches can provide evidence for or against the hypothesis of a primordial gene pool as the source of viral genes, potentially revealing fundamental insights into viral evolution across domains of life .

What are common challenges in recombinant ORF92 expression and purification, and how can they be addressed?

Researchers working with recombinant ORF92 frequently encounter several technical challenges during expression and purification. The table below summarizes these challenges and provides methodological solutions:

ChallengePotential CausesRecommended SolutionsValidation Approaches
Low soluble expressionTransmembrane nature of ORF92, improper folding, toxic effects- Use specialized E. coli strains (e.g., C41(DE3), C43(DE3)) designed for membrane proteins
- Express at lower temperatures (16-20°C)
- Include mild detergents (0.1% DDM, CHAPS) in lysis buffer
- Consider fusion with solubility-enhancing tags (MBP, SUMO)
Western blot comparing soluble vs. insoluble fractions; fluorescence-based protein folding assays
Protein aggregationHydrophobic interactions, improper refolding, loss of structural stability- Include stabilizing agents (10% glycerol, 50-200 mM NaCl)
- Optimize detergent type and concentration
- Implement step-wise dialysis for refolding
- Use size exclusion chromatography as final purification step
Dynamic light scattering; size exclusion chromatography; thermal shift assays
Poor affinity purificationTag inaccessibility, non-specific binding, tag interference- Increase linker length between protein and tag
- Optimize imidazole concentration gradient
- Add low concentrations of detergents to reduce non-specific binding
- Consider dual tagging strategies
SDS-PAGE analysis of elution fractions; western blot with anti-tag antibodies
Degradation during storageProtease contamination, thermally-induced unfolding- Add protease inhibitors during purification
- Store at -80°C in small aliquots
- Add 6% trehalose in Tris/PBS-based storage buffer (pH 8.0)
- Avoid repeated freeze-thaw cycles
Time-course stability analysis by SDS-PAGE; activity assays after various storage conditions

When optimizing ORF92 purification, researchers should implement systematic parameter variation rather than changing multiple variables simultaneously. Recombinant ORF92 should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL, with the addition of 5-50% glycerol (final concentration) for long-term storage at -20°C/-80°C .

How should researchers design control experiments for functional studies of ORF92?

Designing appropriate controls is critical for rigorous functional characterization of ORF92. A comprehensive control strategy should include:

  • Negative Controls:

    • Expression vector without the ORF92 insert, processed identically to the experimental samples

    • Structurally similar but functionally distinct transmembrane proteins from other viruses

    • Heat-denatured ORF92 (particularly relevant given its thermophilic origin)

  • Positive Controls:

    • Well-characterized transmembrane proteins with known functions and measurable activities

    • If specific functions are hypothesized, proteins with similar confirmed functions

  • Internal Controls:

    • Site-directed mutants of ORF92 targeting predicted functional domains

    • Tagged versions of ORF92 with different fusion partners to control for tag effects

    • Dose-response experiments at varying protein concentrations

  • Environmental Controls:

    • Experimental conditions mimicking the native environment (pH 1.5, 93°C) compared to standard conditions

    • Buffer composition controls to account for ions, detergents, or stabilizing agents

For single-case experimental designs (SCED), establishing a representative baseline is crucial, with a minimum of 3-5 data points recommended in each phase of the experiment . Additionally, researchers should consider randomization components to improve methodological rigor and internal validity .

What novel experimental approaches might advance understanding of ORF92's role in ABV biology?

Advancing our understanding of ORF92's function within ABV biology requires innovative experimental approaches that address the unique challenges of studying extremophilic archaeal viruses:

  • Cryo-Electron Tomography: Visualizing ABV virions with ORF92 specifically labeled (via nanobodies or minimal tags) could determine the protein's localization and arrangement within the viral particle, providing structural insights into its functional role.

  • Synthetic Biology Approaches: Reconstructing minimal ABV systems with systematically varied components could reveal essential functions of ORF92 in viral assembly, host recognition, or genome packaging. This could involve creating chimeric viruses where ORF92 is replaced with homologs from other systems.

  • Advanced Imaging of Host-Virus Interactions: Implementing super-resolution microscopy techniques to track fluorescently-tagged ORF92 during the viral infection cycle could elucidate its temporal and spatial distribution, particularly its potential role in membrane interactions.

  • Systems Biology Integration: Combining proteomics, transcriptomics, and metabolomics to characterize host responses to wild-type versus ORF92-mutant viruses could identify pathways affected by this protein, providing functional insights through indirect evidence.

  • Microfluidic High-Throughput Screening: Developing specialized high-throughput screening platforms adapted to extreme conditions could enable testing of ORF92 interactions with libraries of compounds or peptides, potentially revealing binding partners or inhibitors.

These approaches should be designed using rigorous experimental frameworks, incorporating appropriate controls and statistical analyses as outlined in contemporary experimental design standards .

How might comparative analysis of ORF92 with other viral transmembrane proteins from extreme environments contribute to viral taxonomy and evolution models?

Comparative analysis of ORF92 with transmembrane proteins from other extremophilic viruses represents a valuable approach to refining viral taxonomy and evolutionary models. This research direction should implement:

  • Expanded Phylogenomic Analysis: Constructing phylogenetic networks rather than simple trees to account for potential horizontal gene transfer events between viruses from different domains of life. This approach should incorporate the latest viral metagenomic data from extreme environments worldwide.

  • Structural Comparison Methodology: Developing quantitative metrics for comparing structural adaptations to extreme environments across diverse viral lineages, focusing on transmembrane domains that interact directly with challenging environmental conditions.

  • Experimental Reconstruction of Ancestral Sequences: Utilizing ancestral sequence reconstruction algorithms to predict evolutionary precursors of ORF92, followed by laboratory resurrection and functional testing of these predicted ancestors to validate evolutionary models.

  • Horizontal Gene Transfer Analysis: Implementing computational approaches to detect potential horizontal gene transfer events that might explain the observed similarities between ABV genes and those of bacteriophage φ29 and human adenovirus, particularly focused on the DNA replication machinery.

The apparent similarities in putative mechanisms of DNA replication and packaging between ABV and viruses from bacterial and eukaryotic hosts suggest a potential primordial gene pool as a source of viral genes . Testing this hypothesis requires integration of computational predictions with experimental validation through the approaches outlined above.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.